Shares of V2 Retail were locked in a 5 per cent upper circuit at Rs 1,725.90 a piece on the BSE in Friday's intraday trade
The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for the Community-Acquired Bacterial Pneumonia (CABP) in Adults
Markets Today LIVE: Benchmark Indian equity indices BSE Sensex and Nifty50 were trading lower on Friday, amid mixed global cues and a lower close on Wall Street overnight